These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 24325405)

  • 61. Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patients.
    Dzekova-Vidimliski P; Nikolov IG; Matevska-Geshkovska N; Mena S; Rostaing L; Dimovski A; Sikole A
    Ren Fail; 2015 Aug; 37(7):1180-4. PubMed ID: 26156685
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IL28B: A new wager in the skyline of hepatitis C virus infection.
    Mangia A
    Dig Liver Dis; 2011 Mar; 43(3):177-9. PubMed ID: 21237729
    [No Abstract]   [Full Text] [Related]  

  • 63. IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.
    Fattovich G; Covolo L; Bibert S; Askarieh G; Lagging M; Clément S; Malerba G; Pasino M; Guido M; Puoti M; Gaeta GB; Santantonio T; Raimondo G; Bruno R; Bochud PY; Donato F; Negro F;
    Aliment Pharmacol Ther; 2011 May; 33(10):1162-72. PubMed ID: 21443535
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study.
    Hu CC; Lin CL; Chang LC; Chien CH; Chen LW; Liu CJ; Chien RN
    BMC Infect Dis; 2015 Mar; 15():156. PubMed ID: 25888020
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy.
    Shaker OG; Sadik NA
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1842-9. PubMed ID: 23020144
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of genetic polymorphisms near the IL28B gene and amino acid substitutions in the hepatitis C virus core region on interferon sensitivity/resistance in patients with chronic hepatitis C.
    Toyoda H; Kumada T; Tada T; Kawaguchi T; Murakami Y; Matsuda F
    J Med Virol; 2011 Jul; 83(7):1203-11. PubMed ID: 21567424
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of IL28B genotype on hepatitis B and C virus infection.
    Stättermayer AF; Ferenci P
    Curr Opin Virol; 2015 Oct; 14():50-5. PubMed ID: 26284971
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
    Stättermayer AF; Strassl R; Maieron A; Rutter K; Stauber R; Strasser M; Beinhardt S; Datz C; Scherzer TM; Steindl-Munda P; Gschwantler M; Trauner M; Hofer H; Ferenci P
    Aliment Pharmacol Ther; 2014 Jan; 39(1):104-11. PubMed ID: 24205831
    [TBL] [Abstract][Full Text] [Related]  

  • 69. IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection.
    Wu R; Chi X; Wang X; Sun H; Lv J; Gao X; Yu G; Kong F; Xu H; Hua R; Jiang J; Sun B; Zhong J; Pan Y; Niu J
    Infect Genet Evol; 2016 Apr; 39():132-140. PubMed ID: 26820907
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Toward the establishment of a prediction system for the personalized treatment of chronic hepatitis C.
    Ochi H; Hayes CN; Abe H; Hayashida Y; Uchiyama T; Kamatani N; Nakamura Y; Chayama K
    J Infect Dis; 2012 Jan; 205(2):204-10. PubMed ID: 22124128
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Genome-wide association study on and the clinical application to chronic hepatitis C].
    Sugiyama M; Mizokami M
    Uirusu; 2011 Jun; 61(1):15-24. PubMed ID: 21972552
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene.
    Watanabe T; Sugauchi F; Tanaka Y; Matsuura K; Yatsuhashi H; Murakami S; Iijima S; Iio E; Sugiyama M; Shimada T; Kakuni M; Kohara M; Mizokami M
    Gut; 2013 Sep; 62(9):1340-6. PubMed ID: 23135762
    [TBL] [Abstract][Full Text] [Related]  

  • 73. IL28B polymorphisms and chronic hepatitis C.
    Chevaliez S; Hézode C
    Gastroenterol Clin Biol; 2010 Nov; 34(11):587-9. PubMed ID: 20889274
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetics of IL28B and HCV--response to infection and treatment.
    Hayes CN; Imamura M; Aikata H; Chayama K
    Nat Rev Gastroenterol Hepatol; 2012 May; 9(7):406-17. PubMed ID: 22641049
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
    Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
    J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.
    Rauch A; Kutalik Z; Descombes P; Cai T; Di Iulio J; Mueller T; Bochud M; Battegay M; Bernasconi E; Borovicka J; Colombo S; Cerny A; Dufour JF; Furrer H; Günthard HF; Heim M; Hirschel B; Malinverni R; Moradpour D; Müllhaupt B; Witteck A; Beckmann JS; Berg T; Bergmann S; Negro F; Telenti A; Bochud PY; ;
    Gastroenterology; 2010 Apr; 138(4):1338-45, 1345.e1-7. PubMed ID: 20060832
    [TBL] [Abstract][Full Text] [Related]  

  • 77. IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late?
    Jensen DM; Pol S
    Liver Int; 2012 Feb; 32 Suppl 1():74-8. PubMed ID: 22212576
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.
    Dill MT; Duong FH; Vogt JE; Bibert S; Bochud PY; Terracciano L; Papassotiropoulos A; Roth V; Heim MH
    Gastroenterology; 2011 Mar; 140(3):1021-31. PubMed ID: 21111740
    [TBL] [Abstract][Full Text] [Related]  

  • 79. IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.
    Suppiah V; Gaudieri S; Armstrong NJ; O'Connor KS; Berg T; Weltman M; Abate ML; Spengler U; Bassendine M; Dore GJ; Irving WL; Powell E; Hellard M; Riordan S; Matthews G; Sheridan D; Nattermann J; Smedile A; Müller T; Hammond E; Dunn D; Negro F; Bochud PY; Mallal S; Ahlenstiel G; Stewart GJ; George J; Booth DR;
    PLoS Med; 2011 Sep; 8(9):e1001092. PubMed ID: 21931540
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C.
    Umemura T; Joshita S; Yoneda S; Katsuyama Y; Ichijo T; Matsumoto A; Yoshizawa K; Ota M; Tanaka E
    Antivir Ther; 2011; 16(7):1073-80. PubMed ID: 22024523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.